Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca

HAMILTON, ON and BOSTON, May 29, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines,...

Related Keywords

Canada ,Boston ,Massachusetts ,United States ,Canadian ,Amanda Cray ,Us Securities Exchange Commission ,Investor Relations Corporate Communications ,Nasdaq ,Us Securities Exchange ,Fusion Pharmaceuticals ,Astrazeneca ,Prnewswire Fusion Pharmaceuticals Inc ,Canada Business Corporations Act ,Multilateral Instrument ,Minority Security Holders ,Good Manufacturing Practice ,Exchange Act ,Note Regarding Forward Looking ,Annual Report ,Exchange Commission ,Senior Director ,Investor Relations ,Corporate Communications ,